N. I. Lobachevsky National Research State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
B. A. Korolev Specialized Cardiac Surgery Clinical Hospital, Nizhny Novgorod, Russia.
Bull Exp Biol Med. 2022 Sep;173(5):602-605. doi: 10.1007/s10517-022-05595-z. Epub 2022 Oct 10.
We studied the effect of molecular hydrogen (H) on the content of 2,3-diphosphoglyceric acid (2,3-DPG), ATP, malondialdehyde, and catalase activity in erythrocytes in chronic heart failure. Inhalation of 2% molecular hydrogen H was carried out for 40 min repeatedly (5 days) or once. Inhalation of H caused an increase in ATP concentration in both research groups, but was more pronounced after repeated inhalation. The content of 2,3-DPG increased after repeated exposure to H. The increase in metabolic activity under the effect of H was accompanied by a decrease in malondialdehyde concentration and an increase in catalase activity. Thus, the application of H in chronic heart failure reduced oxidative stress and improved metabolism of erythrocytes, which contributes to improvement of microcirculation. This allows us to recommend H for protection against ischemic and reperfusion damage to the myocardium.
我们研究了分子氢(H)对慢性心力衰竭患者红细胞中 2,3-二磷酸甘油酸(2,3-DPG)、ATP、丙二醛和过氧化氢酶活性含量的影响。我们反复(共 5 天,每天 40 分钟)或一次性吸入 2%的分子氢 H。在这两项研究中,吸入 H 均能增加 ATP 浓度,但反复吸入 H 的效果更为显著。重复接触 H 后,2,3-DPG 的含量增加。H 的作用下代谢活性的增加伴随着丙二醛浓度的降低和过氧化氢酶活性的增加。因此,在慢性心力衰竭中应用 H 可以减少氧化应激,改善红细胞的代谢,有助于改善微循环。这使我们能够推荐 H 用于保护心肌免受缺血再灌注损伤。